Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

48 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Induction of multiple pituitary adenylate cyclase activating polypeptide (PACAP) transcripts through alternative cleavage and polyadenylation of proPACAP precursor mRNA.
Harakall SA, Brandenburg CA, Gilmartin GA, May V, Braas KM. Harakall SA, et al. Ann N Y Acad Sci. 1998 Dec 11;865:367-74. doi: 10.1111/j.1749-6632.1998.tb11197.x. Ann N Y Acad Sci. 1998. PMID: 9928031
A comparison of the determination and speciation of inorganic arsenic using general HPLC methodology with UV, MS and MS/MS detection.
Gilmartin G, Gingrich D. Gilmartin G, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Apr 15;1083:20-27. doi: 10.1016/j.jchromb.2018.02.034. Epub 2018 Feb 26. J Chromatogr B Analyt Technol Biomed Life Sci. 2018. PMID: 29518633
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial.
Bleecker ER, FitzGerald JM, Chanez P, Papi A, Weinstein SF, Barker P, Sproule S, Gilmartin G, Aurivillius M, Werkström V, Goldman M; SIROCCO study investigators. Bleecker ER, et al. Among authors: gilmartin g. Lancet. 2016 Oct 29;388(10056):2115-2127. doi: 10.1016/S0140-6736(16)31324-1. Epub 2016 Sep 5. Lancet. 2016. PMID: 27609408 Clinical Trial.
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial.
FitzGerald JM, Bleecker ER, Nair P, Korn S, Ohta K, Lommatzsch M, Ferguson GT, Busse WW, Barker P, Sproule S, Gilmartin G, Werkström V, Aurivillius M, Goldman M; CALIMA study investigators. FitzGerald JM, et al. Among authors: gilmartin g. Lancet. 2016 Oct 29;388(10056):2128-2141. doi: 10.1016/S0140-6736(16)31322-8. Epub 2016 Sep 5. Lancet. 2016. PMID: 27609406 Clinical Trial.
Effect of ivacaftor in patients with advanced cystic fibrosis and a G551D-CFTR mutation: Safety and efficacy in an expanded access program in the United States.
Taylor-Cousar J, Niknian M, Gilmartin G, Pilewski JM; VX11-770-901 investigators. Taylor-Cousar J, et al. Among authors: gilmartin g. J Cyst Fibros. 2016 Jan;15(1):116-22. doi: 10.1016/j.jcf.2015.01.008. Epub 2015 Feb 11. J Cyst Fibros. 2016. PMID: 25682022 Free article. Clinical Trial.
Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST).
McKone EF, Borowitz D, Drevinek P, Griese M, Konstan MW, Wainwright C, Ratjen F, Sermet-Gaudelus I, Plant B, Munck A, Jiang Y, Gilmartin G, Davies JC; VX08-770-105 (PERSIST) Study Group. McKone EF, et al. Among authors: gilmartin g. Lancet Respir Med. 2014 Nov;2(11):902-910. doi: 10.1016/S2213-2600(14)70218-8. Epub 2014 Oct 9. Lancet Respir Med. 2014. PMID: 25311995 Clinical Trial.
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation.
De Boeck K, Munck A, Walker S, Faro A, Hiatt P, Gilmartin G, Higgins M. De Boeck K, et al. Among authors: gilmartin g. J Cyst Fibros. 2014 Dec;13(6):674-80. doi: 10.1016/j.jcf.2014.09.005. Epub 2014 Sep 26. J Cyst Fibros. 2014. PMID: 25266159 Free article. Clinical Trial.
Clinical drug-drug interaction assessment of ivacaftor as a potential inhibitor of cytochrome P450 and P-glycoprotein.
Robertson SM, Luo X, Dubey N, Li C, Chavan AB, Gilmartin GS, Higgins M, Mahnke L. Robertson SM, et al. Among authors: gilmartin gs. J Clin Pharmacol. 2015 Jan;55(1):56-62. doi: 10.1002/jcph.377. Epub 2014 Aug 27. J Clin Pharmacol. 2015. PMID: 25103957 Clinical Trial.
The structure of human cleavage factor I(m) hints at functions beyond UGUA-specific RNA binding: a role in alternative polyadenylation and a potential link to 5' capping and splicing.
Yang Q, Gilmartin GM, Doublié S. Yang Q, et al. Among authors: gilmartin gm. RNA Biol. 2011 Sep-Oct;8(5):748-53. doi: 10.4161/rna.8.5.16040. Epub 2011 Sep 1. RNA Biol. 2011. PMID: 21881408 Free PMC article. Review.
48 results
Jump to page
Feedback